Skip to main content
. 2017 Mar 1;8(20):32523–32535. doi: 10.18632/oncotarget.15808

Table 1. Comparison of recurrence in patients with HCC and midkine-elevated or midkine-normal levels.

Midkine-elevated (n = 238) Midkine-normal (n = 103) p
Recurrence, n (%) 182 (76.5) 63 (61.2) 0.004
Intrahepatic recurrence, n (%) 147 (61.8) 48 (46.6) 0.009
Extrahepatic recurrence, n (%) 58 (24.4) 12 (11.7) 0.008
Intra+extrahepatic recurrence, n (%) 60 (25.2) 17 (16.5) 0.078
Interval of recurrence, months 18.6 ± 5.2 21.6 ± 4.8 0.001